Horizon Therapeutics Public Ltd Co Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Horizon Therapeutics Public Ltd Co quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Entity Common Stock, Shares Outstanding for the quarter ending August 2, 2023 was 229M shares, a 0.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 229M -1.39M -0.6% Aug 2, 2023 10-Q 2023-08-08
Q1 2023 229M -1.26M -0.55% Apr 27, 2023 10-Q 2023-05-03
Q3 2022 227M -200K -0.09% Oct 27, 2022 10-Q 2022-11-02
Q2 2022 230M +4.49M +1.99% Jul 28, 2022 10-Q 2022-08-03
Q1 2022 230M +5.12M +2.28% Apr 28, 2022 10-Q 2022-05-04
Q3 2021 227M +6.11M +2.77% Oct 28, 2021 10-Q 2021-11-03
Q2 2021 226M +19.4M +9.41% Jul 29, 2021 10-Q 2021-08-04
Q1 2021 225M +34M +17.8% Apr 29, 2021 10-Q 2021-05-05
Q3 2020 221M +33.4M +17.8% Oct 28, 2020 10-Q 2020-11-02
Q2 2020 206M +20M +10.7% Jul 31, 2020 10-Q 2020-08-05
Q1 2020 191M +5.89M +3.19% May 1, 2020 10-Q 2020-05-06
Q3 2019 187M +19.7M +11.7% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 186M +19.8M +11.9% Aug 1, 2019 10-Q 2019-08-07
Q1 2019 185M +19.8M +12% May 1, 2019 10-Q 2019-05-08
Q3 2018 168M +3.74M +2.28% Oct 26, 2018 10-Q 2018-11-07
Q2 2018 167M +3.28M +2.01% Jul 27, 2018 10-Q 2018-08-08
Q1 2018 165M +2.33M +1.43% Apr 27, 2018 10-Q 2018-05-09
Q3 2017 164M +2.63M +1.63% Oct 27, 2017 10-Q 2017-11-06
Q2 2017 163M +2.45M +1.52% Jul 28, 2017 10-Q 2017-08-07
Q1 2017 163M +2.35M +1.47% Apr 28, 2017 10-Q 2017-05-08
Q3 2016 161M +1.96M +1.23% Nov 2, 2016 10-Q 2016-11-07
Q2 2016 161M +1.7M +1.07% Jul 29, 2016 10-Q 2016-08-08
Q1 2016 160M +5.86M +3.79% Apr 29, 2016 10-Q 2016-05-09
Q3 2015 159M +40.4M +34% Nov 2, 2015 10-Q 2015-11-06
Q2 2015 159M +84.4M +113% Aug 3, 2015 10-Q 2015-08-07
Q1 2015 154M +86.8M +128% May 1, 2015 10-Q 2015-05-08
Q3 2014 119M +53M +80.5% Nov 3, 2014 10-Q 2014-11-06
Q2 2014 74.8M +10.3M +15.9% Aug 5, 2014 10-Q 2014-08-07
Q1 2014 67.7M +5.79M +9.34% Mar 11, 2014 10-K 2014-03-13
Q3 2013 65.9M +4.27M +6.94% Nov 5, 2013 10-Q 2013-11-08
Q2 2013 64.5M +30.7M +90.9% Aug 6, 2013 10-Q 2013-08-09
Q1 2013 61.9M +28.2M +83.8% Mar 13, 2013 10-K 2013-03-18
Q3 2012 61.6M +42.1M +215% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 33.8M Aug 7, 2012 10-Q 2012-08-10
Q1 2012 33.7M Mar 15, 2012 10-K 2012-03-23
Q3 2011 19.5M Aug 31, 2011 10-Q 2011-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.